Welcome to CDC Stacks | Wound Botulism in Injection Drug Users - 16590 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Wound Botulism in Injection Drug Users
  • Published Date:
    Jun 2007
  • Source:
    Emerg Infect Dis. 13(6):942-943.
Filetype[PDF - 94.59 KB]


No Related Documents.
You May Also Like:
  1. Paenibacillus larvae Bacteremia in Injection Drug Users
    Personal Author:
    Rieg, Siegbert; Bauer, Tilman Martin; Peyerl-Hoffmann, Gabriele; Held, Jürgen; Ritter, Wolfgang; Wagner, Dirk; Kern, Winfried Vinzenz; Serr, Annerose;
    Published:
    Mar 2010
    Source:
    Emerg Infect Dis. 16(3):487-489.
    Description:
    Paenibacillus larvae causes American foulbrood in honey bees. We describe P. larvae bacteremia in 5 injection drug users who had self-injected honey-prepared methadone proven to contain P. larvae spores. That such preparations may be contaminated wit...
    File Type:
    Filetype[PDF - 280.48 KB]
  2. Drug Trafficking Routes and Hepatitis B in Injection Drug Users, Manipur, India
    Personal Author:
    Datta, Sibnarayan; Banerjee, Arup; Chandra, Partha K.; Mahapatra, Pradip K.; Chakrabarti, Shekhar; Chakravarty, Runu;
    Published:
    Dec 2006
    Source:
    Emerg Infect Dis. 12(12):1954-1957.
    Description:
    Prevalence of hepatitis B genotype C in injection drug users in the northeastern Indian state of Manipur, neighboring the "Golden Triangle," correlates well with overland drug-trafficking routes, the injection drug use epidemic, and the spread of HIV...
    File Type:
    Filetype[PDF - 314.52 KB]
  3. Syringe disinfection for injection drug users
    Corporate Author:
    Centers for Disease Control and Prevention (U.S.); Academy for Educational Development. Center on AIDS & Community Health.;
    Published:
    July 2004
    Series:
    IDU/HIV prevention
    Description:
    For 20 years, syringe disinfection has been a part of HIV prevention efforts for injection drug users (IDUs). Questions about it persist, however, because of limited scientific studies, varying recommendations on the right way to disinfect, and evide...
    File Type:
    Filetype[PDF - 131.19 KB]
  4. Enrollment Characteristics and Risk Behaviors of Injection Drug Users Participating in the Bangkok Tenofovir Study, Thailand
    Personal Author:
    Martin, Michael.; Vanichseni, Suphak.; Suntharasamai, Pravan.; Sangkum, Udomsak.; Chuachoowong, Rutt.; Mock, Philip A.; Leethochawalit, Manoj.; Chiamwongpaet, Sithisat.; Kittimunkong, Somyot.; van Griensven, Frits.; McNicholl, Janet M.; Paxton, Lynn.; Choopanya, Kachit.;
    Corporate Author:
    for the Bangkok Tenofovir Study Group
    Published:
    Sep 28 2011
    Source:
    PLoS One. 2011; 6(9).
    Description:
    Background : The Bangkok Tenofovir Study was launched in 2005 to determine if pre-exposure prophylaxis with tenofovir will reduce the risk of HIV infection among injecting drug users (IDUs). We describe recruitment, screening, enrollment, and baselin...
    File Type:
    Filetype[PDF - 155.39 KB]
  5. Analysis of Anthrax Immune Globulin Intravenous with Antimicrobial Treatment in Injection Drug Users, Scotland, 2009–2010
    Personal Author:
    Cui, Xizhong; Nolen, Leisha D.; Sun, Junfeng; Booth, Malcolm; Donaldson, Lindsay; Quinn, Conrad P.; Boyer, Anne E.; Hendricks, Katherine; Shadomy, Sean; Bothma, Pieter; Judd, Owen; McConnell, Paul; Bower, William A.; Eichacker, Peter Q.;
    Published:
    Jan 2017
    Source:
    Emerg Infect Dis. 23(1):56-65.
    Description:
    We studied anthrax immune globulin intravenous (AIG-IV) use from a 2009-2010 outbreak of Bacillus anthracis soft tissue infection in injection drug users in Scotland, UK, and we compared findings from 15 AIG-IV recipients with findings from 28 nonrec...
    File Type:
    Filetype[PDF - 956.43 KB]